Description

Legend Biotech is seeking a Director, HCP Professional Promotion Marketing as part of the Commercial team based in Bridgewater, NJ.

Role Overview

Legend Biotech is seeking a senior marketing leader to drive HCP professional promotion for CARVYKTI ® (ciltacabtagene autoleucel; cilta-cel), a BCMA-directed, bivalent CAR-T cell therapy approved for relapsed or refractory multiple myeloma. This is a high-impact role at the commercial center of one of the most scientifically significant therapies in hematologic oncology.

The person in this role will own HCP-facing professional promotion strategy and execution for CARVYKTI in the US, spanning message development and campaign delivery through field force enablement and agency management. They will operate within a co-promotion alliance with Johnson & Johnson, requiring sophisticated cross-organizational collaboration alongside clear internal accountability. The role demands both scientific fluency and commercial judgment: CARVYKTI's clinical profile, including data from the CARTITUDE program, is compelling, and communicating it accurately and persuasively to hematologist-oncologists across academic and community settings is the core of this job.

This position requires a candidate who is comfortable with the operational complexity specific to CAR-T cell therapies, including authorized treatment center dynamics, patient identification and referral pathways, and the leukapheresis-to-infusion logistics that shape the prescriber experience. It also requires someone who can navigate a competitive CAR-T landscape with scientific rigor and strategic clarity.

Key Responsibilities

Strategy and brand planning

• Lead the development of annual HCP professional promotion marketing plans grounded in customer insights, competitive intelligence, and the evolving CARVYKTI evidence base.
• Translate CARTITUDE program data and the broader multiple myeloma treatment landscape into differentiated positioning and messaging for community and academic hematologist-oncologists, with language that will hold up through medical, legal, and regulatory review.
• Monitor competitive dynamics, including other BCMA-directed CAR-T therapies and bispecific antibodies, and translate signals into actionable strategic recommendations.
• Identify and prioritize market opportunities, with particular focus on patient identification, community oncologist education, and authorized treatment center support.

J&J alliance and cross-functional execution

• Partner with Johnson & Johnson across all aspects of HCP professional promotion, including message development, content creation, agency alignment, and tactical execution, while maintaining clear accountability for Legend's strategic priorities.
• Collaborate with nurse, NPP/omnichannel, patient marketing, and market development leads to ensure consistency across all HCP and patient-facing marketing functions.
• Work with the Key Customer Engagement Team to incorporate HCP insights into strategy and execution.
• Partner with insights and analytics to initiate and interpret market research that deepens understanding of the CARVYKTI customer, the myeloma disease environment, and the CAR-T treatment landscape.
• Collaborate with sales training and the head of sales to equip the field force with strategy, messaging, and materials that are accurate, compelling, and field-ready.

Agency and budget management

• Manage professional promotion agency partners to deliver plans and tactics on time and within budget.
• Own HCP key performance indicators and develop reporting frameworks to evaluate and measure promotional effectiveness and ROI.
• Prepare and deliver presentations to senior leadership and other internal and external audiences.

Compliance and regulatory adherence

• Ensure all promotional activities comply with applicable laws, regulations, and FDA promotional guidelines governing commercial interactions with healthcare professionals and other business partners.
• Lead medical, legal, and regulatory review submissions for professional promotion materials, maintaining documentation standards and incorporating review feedback efficiently.

Requirements

• BA/BS required; MBA or advanced science degree a plus.
• Significant pharmaceutical marketing experience, with meaningful time in HCP-facing brand roles; oncology required.
• Deep knowledge of hematology/oncology strongly preferred; familiarity with multiple myeloma treatment paradigms, BCMA-directed therapeutics, or CAR-T/cellular therapy is a meaningful differentiator.
• Experience operating within co-promotion alliances or complex multi-stakeholder commercial environments preferred.
• Familiarity with the access and operational dynamics of specialty cell therapies, including authorized treatment center infrastructure and the leukapheresis-to-infusion patient journey, is a plus.
• Demonstrated ability to translate complex clinical data into clear, compelling, and compliant HCP-facing communications.
• Strong strategic thinking: able to synthesize competitive intelligence, market data, and customer insights into actionable brand strategy.
• Proven cross-functional leadership: comfortable influencing without authority across alliance partners, internal functions, and agency teams.
• Exceptional written and oral communication skills, including executive-level presentation capability.
• Self-directed and highly accountable, with strong project management skills and the ability to manage multiple priorities simultaneously.
• Entrepreneurial orientation: comfortable operating in fast-moving, complex environments where not all answers are defined.
• Willingness to travel approximately 25% as required by business need.

#Li-JK1

#Li-Hybrid

Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.

Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.

Please note: These benefits are offered exclusively to permanent full-time employees. Contractors are not eligible for benefits through Legend Biotech.

EEO Statement

It is the policy of Legend Biotech to provide equal employment opportunities without regard to actual or perceived race, color, creed, religion, national origin, ancestry, citizenship status, age, sex or gender (including pregnancy, childbirth, related medical conditions and lactation), gender identity or gender expression (including transgender status), sexual orientation, marital status, military service and veteran status, disability, genetic information, or any other protected characteristic under applicable federal, state or local laws or ordinances.

Employment is at-will and may be terminated at any time with or without cause or notice by the employee or the company.

For information related to our privacy notice, please review: Legend Biotech Privacy Notice .